Sartorius
Stock
Stock
ISIN: DE0007165607
Ticker: SRT
DE0007165607
SRT
Price
Price
CHART BY
Frequently asked questions
What is Sartorius's market capitalization?
The market capitalization of Sartorius is $18.01B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Sartorius's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Sartorius is 73.67. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Sartorius?
Sartorius's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.54. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Sartorius's stock?
Currently, 6 analysts cover Sartorius's stock, with a consensus target price of $273.65. Analyst ratings provide insights into the stock's expected performance.
What is Sartorius's revenue over the trailing twelve months?
Over the trailing twelve months, Sartorius reported a revenue of $4.10B.
What is the EBITDA for Sartorius?
Sartorius's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.21B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Sartorius?
Sartorius has a free cash flow of $357.70M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Sartorius have, and what sector and industry does it belong to?
Sartorius employs approximately 14,042 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Sartorius's shares?
The free float of Sartorius is 1.50M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $18.01B
- EPS (TTM)
- $3.54
- Free Float
- 1.50M
- P/E ratio (TTM)
- 73.67
- Revenue (TTM)
- $4.10B
- EBITDA (TTM)
- $1.21B
- Free Cashflow (TTM)
- $357.70M
Pricing
- 1D span
- $253.15$260.51
- 52W span
- $183.74$264.97
Analyst Ratings
The price target is $273.65 and the stock is covered by 6 analysts.
Buy
3
Hold
3
Sell
0
Information
Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through the Bioprocess Solutions (BPS) and Lab Products and Service (LPS) segment. The BPS segment focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The LPS segment serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.
- Employees
- 14,042
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- DE0007165607
- Primary Ticker
- SRT
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet